BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 21244849)

  • 21. Caffeic acid inhibits organic anion transporters OAT1 and OAT3 in rat kidney.
    Uwai Y; Kawasaki T; Nabekura T
    Drug Metabol Drug Interact; 2013; 28(4):247-50. PubMed ID: 24166669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of Mardin-Darby canine kidney cells stably expressing human organic anion transporters.
    Shin HJ; Lee CH; Park SJ; Shin JG; Song IS
    Arch Pharm Res; 2010 May; 33(5):709-16. PubMed ID: 20512469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3.
    Aslamkhan AG; Thompson DM; Perry JL; Bleasby K; Wolff NA; Barros S; Miller DS; Pritchard JB
    Am J Physiol Regul Integr Comp Physiol; 2006 Dec; 291(6):R1773-80. PubMed ID: 16857889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organic anion transporters involved in the excretion of bestatin in the kidney.
    Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
    Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport of organic anions across the basolateral membrane of proximal tubule cells.
    Burckhardt BC; Burckhardt G
    Rev Physiol Biochem Pharmacol; 2003; 146():95-158. PubMed ID: 12605306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices.
    Nozaki Y; Kusuhara H; Kondo T; Hasegawa M; Shiroyanagi Y; Nakazawa H; Okano T; Sugiyama Y
    J Pharmacol Exp Ther; 2007 Apr; 321(1):362-9. PubMed ID: 17255469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Directing role of organic anion transporters in the excretion of mercapturic acids of alkylated polycyclic aromatic hydrocarbons.
    Bakhiya N; Batke M; Laake J; Monien BH; Frank H; Seidel A; Engst W; Glatt H
    Drug Metab Dispos; 2007 Oct; 35(10):1824-31. PubMed ID: 17639024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.
    Truong DM; Kaler G; Khandelwal A; Swaan PW; Nigam SK
    J Biol Chem; 2008 Mar; 283(13):8654-63. PubMed ID: 18174163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.
    Nagle MA; Wu W; Eraly SA; Nigam SK
    Neurosci Lett; 2013 Feb; 534():133-8. PubMed ID: 23196129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels.
    Buist SC; Klaassen CD
    Drug Metab Dispos; 2004 Jun; 32(6):620-5. PubMed ID: 15155553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1).
    Wu T; Li H; Chen J; Cao Y; Fu W; Zhou P; Pang J
    Pharmacol Rep; 2017 Dec; 69(6):1254-1262. PubMed ID: 29128807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
    Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
    Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid.
    Nakagawa H; Hirata T; Terada T; Jutabha P; Miura D; Harada KH; Inoue K; Anzai N; Endou H; Inui K; Kanai Y; Koizumi A
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):1-8. PubMed ID: 18373647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of rat renal cortical organic anion transporter (OAT1 and OAT3) expression in response to ischemia/reperfusion injury.
    Zhang R; Yang X; Li J; Wu J; Peng WX; Dong XQ; Zhou SF; Yu XQ
    Am J Nephrol; 2008; 28(5):772-83. PubMed ID: 18441523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal organic anion transporters OAT1 and OAT3 mediate the cellular accumulation of 5-sulfooxymethylfurfural, a reactive, nephrotoxic metabolite of the Maillard product 5-hydroxymethylfurfural.
    Bakhiya N; Monien B; Frank H; Seidel A; Glatt H
    Biochem Pharmacol; 2009 Aug; 78(4):414-9. PubMed ID: 19394312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.
    Wolff NA; Burckhardt BC; Burckhardt G; Oellerich M; Armstrong VW
    Nephrol Dial Transplant; 2007 Sep; 22(9):2497-503. PubMed ID: 17526543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of the metal chelator DMPS with OAT1 and OAT3 in intact isolated rabbit renal proximal tubules.
    Lungkaphin A; Chatsudthipong V; Evans KK; Groves CE; Wright SH; Dantzler WH
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F68-76. PubMed ID: 13129851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).
    Lalanne S; Le Vée M; Lemaitre F; Le Corre P; Verdier MC; Fardel O
    Fundam Clin Pharmacol; 2020 Aug; 34(4):476-483. PubMed ID: 32100322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Interaction of Dantrolene, Glafenine, Nalidixic Acid, and Prazosin with Human Organic Anion Transporters 1 and 3.
    Burckhardt BC; Henjakovic M; Hagos Y; Burckhardt G
    J Pharmacol Exp Ther; 2017 Sep; 362(3):450-458. PubMed ID: 28630284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.